Abstract C051: MDM2 inhibitor KRT-232 extends survival in glioblastoma patient-derived xenograft modelsAnn C. Mladek, Jann N. Sarkaria, William F. Elmquist et al.|Molecular Cancer Therapeutics|2019Cited by 3